FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

LumiThera’s Dry AMD Treatment Device Gains CE Mark

June 25, 2018
A A

LumiThera’s LT-300 device, used for treating dry advanced macular degeneration, has earned a CE Mark.

The device uses the company’s LT-300 light delivery system to treat patients who suffer from a loss of central vision.

The treatment incorporates low level light therapy, applying red and near-infrared light to improve and repair tissue that has experienced degeneration or injury.

View today's stories